# A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

> **NCT00314158** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 523 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension
- **DRUG:** Brinzolamide 10 mg/ml (AZOPT) eye drops, suspension
- **DRUG:** Timolol 5 mg/ml eye drops, solution

## Key facts

- **NCT ID:** NCT00314158
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 523 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314158, "A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00314158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*